Lloyd Segal

Therapure Biopharma, Inc. engages in the business of contract development and manufacturing. It operates through the following divisions: Therapure Biomanufacturing, Therapure Innovations, and Evolve Biologics. The Therapure Biomanufacturing division focuses on contract development and manufacturing of complex biologics. The Therapure Innovations division includes in-house proprietary-drug development. The Evolve Biologics division develops a portfolio of plasma-derived pharmaceutical products. The company was founded on June 22, 2007 and is headquartered in Mississauga, Canada.

Pembroke American Growth Fund, Inc. is an open-end investment fund. The company distributes earnings to unit holders as income, dividends or capital gains. It holds interest in pursing long-term growth through capital appreciation by investing in smaller U.S. companies to have above-average growth potential or to be undervalued. The company was founded on October 1, 1988 and is headquartered in Montreal, Canada.

Aktis Oncology, Inc. is a biotechnology company located in Boston, MA. The company specializes in the discovery and development of a new class of targeted alpha radiopharmaceuticals to treat a broad range of solid tumor cancers. The company's molecules are designed for high tumor penetration and long residence time, which maximizes tumor elimination while minimizing side effects of treatment. The approach enables clinicians to visualize and verify target engagement prior to exposure to therapeutic radioisotopes. Founded and incubated by MPM Capital, Aktis Oncology has developed proprietary platforms to generate tumor targeting agents with ideal properties for alpha radiotherapy. Matt M. Roden has been the CEO of the company since 2020.

Biovail Corp. develops and manufactures pharmaceutical products. The company provides different types of products which include Wellbutrin SR, Retavase, Zyban and Tiazac XC in Canada and Zovirax Ointment and Zovirax Cream in the United States. Its products are used for cardiovascular disease, central nervous system disorders, pain management and other niche areas. It was founded on March 29, 1994 and is headquartered in Mississauga, Canada.

Part of Nen Tm Life Science Products, Inc., Advanced Bioconcept Ltd. is a Canadian company that makes proprietary, fluorescent labeled peptides. The private company is based in Montréal, Canada. The company was founded by Clarissa Desjardins. Advanced Bioconcept was acquired by Nen Tm Life Science Products, Inc. on September 25, 1998.